We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Partnership Developed to Create Tools to Speed Contaminant Detection

By LabMedica International staff writers
Posted on 05 Oct 2009
Millipore (Billerica, MA, USA) and the newly created Roka Bioscience reported they are jointly developing molecular assays and portable instruments for biopharmaceutical production. Roka is a spinoff of Gen-Probe (San Diego, CA, USA).

The joint effort is focused on accelerating the detection of microbial contamination so biopharma manufacturers can take corrective actions earlier in the production process, limiting contamination impact. The earlier intervention is expected to reduce downstream processing risks and optimize product yields.

The work is based on a Millipore and Gen-Probe partnership dating to 2005. It led to the MilliProbe system, which combines Millipore sample prep methodologies with Gen-Probe nucleic acid technologies for speed and sensitivity in one microbial screening application. MilliProbe utilizes real-time transcription-mediated amplification technology to detect contaminants.

The partners have one assay on the market for Pseudomonas aeruginosa and are developing a second assay for Mycoplasma.

Related Links:

Millipore
Gen-Probe



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
POC Immunoassay Analyzer
Procise DX

Latest Industry News

Integrated DNA Technologies Expands into Clinical Diagnostics
05 Oct 2009  |   Industry

Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
05 Oct 2009  |   Industry

Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
05 Oct 2009  |   Industry



INTEGRA BIOSCIENCES AG